Neuroendocrine Tumors Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Neuroendocrine Tumors stocks.

Neuroendocrine Tumors Stocks Recent News

Date Stock Title
May 10 CRNX Crinetics Pharmaceuticals Announces May 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 10 CRNX Crinetics Pharmaceuticals Inc (CRNX) Reports Q1 2024 Financial Results
May 9 CRNX Crinetics Pharmaceuticals, Inc. (CRNX) Reports Q1 Loss, Misses Revenue Estimates
May 9 AQST Aquestive Therapeutics, Inc. (NASDAQ:AQST) Q1 2024 Earnings Call Transcript
May 9 CRNX Crinetics Pharmaceuticals GAAP EPS of -$0.93 misses by $0.13, revenue of $0.6M beats by $0.42M
May 9 CRNX Crinetics Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update
May 9 RANI Rani Therapeutics to Present Clinical and Preclinical Data on Oral Delivery of an Ustekinumab Biosimilar via the RaniPill® Capsule at Digestive Disease Week 2024
May 9 AQST Aquestive Therapeutics to Participate in The Citizens JMP Life Sciences Conference
May 9 AQST Aquestive Therapeutics, Inc. (NASDAQ:AQST) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year
May 9 RANI RANI: 1Q:24 Results
May 9 AQST Aquestive Therapeutics Inc (AQST) Q1 2024 Earnings Call Transcript Highlights: Navigating ...
May 8 CRNX Crinetics Pharmaceuticals Q1 2024 Earnings Preview
May 8 CRNX Crinetics Pharmaceuticals to Present Advancements from Atumelnant (CRN04894) and Paltusotine Development Programs at ENDO 2024
May 8 AQST Aquestive Therapeutics, Inc. (AQST) Q1 2024 Earnings Call Transcript
May 8 AQST Aquestive Therapeutics, Inc. 2024 Q1 - Results - Earnings Call Presentation
May 8 RANI Rani Therapeutics Q1 2024 Earnings: Financial Performance and Strategic Updates
May 7 AQST Compared to Estimates, Aquestive Therapeutics (AQST) Q1 Earnings: A Look at Key Metrics
May 7 AQST Aquestive Therapeutics GAAP EPS of -$0.17, revenue of $12.05M
May 7 AQST Aquestive Therapeutics (AQST) Reports Q1 Loss, Misses Revenue Estimates
May 7 AQST Aquestive Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
Neuroendocrine Tumors

Neuroendocrine tumors (NETs) are a type of cancer that can occur in various parts of the body, including the lungs, pancreas, and gastrointestinal tract. They are usually slow-growing and can produce hormones that can cause a variety of symptoms. Treatment for NETs depends on the size and location of the tumor, as well as the patient's overall health.

Browse All Tags